Keyphrases
Metabolic-associated Fatty Liver Disease (MAFLD)
100%
Non-alcoholic Fatty Liver Disease (NAFLD)
50%
Clinical Trial Design
25%
Approved Drugs
25%
Pharmacotherapy
25%
Drug Development
25%
Drug Therapy
25%
Response Rate
25%
Fatty Liver
25%
Design Development
25%
Metabolic Dysfunction
25%
Patient Stratification
25%
Clinical Trial Drugs
25%
Patient Heterogeneity
25%
Medicine and Dentistry
Non-Alcoholic Fatty Liver Disease
100%
Drug Therapy
50%
Nonalcoholic Fatty Liver
50%
Fatty Liver
50%
Clinical Trial Design
25%
Diseases
25%
Pharmacology, Toxicology and Pharmaceutical Science
Fatty Liver
100%
Pharmacotherapy
50%
Nonalcoholic Fatty Liver
50%
Clinical Trial Design
25%
Drug Development
25%
Diseases
25%
Biochemistry, Genetics and Molecular Biology
Drug Therapy
100%
Clinical Trial Design
50%
Immunology and Microbiology